Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Evaluation of remote pulmonary function testing in motor neuron disease

Epidemiology of amyotrophic lateral sclerosis in Friuli-Venezia Giulia, North-Eastern Italy, 2002–2014: a retrospective population-based study

Radicava (edaravone) for amyotrophic lateral sclerosis: US experience at 1 year after launch

The feasibility of using robotic technology to quantify sensory, motor, and cognitive impairments associated with ALS

Post-hoc analyses of the edaravone clinical trials Study 16 and Study 19: a step toward more efficient clinical trial designs in amyotrophic lateral sclerosis

HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation

The project MinE databrowser: bringing large-scale whole-genome sequencing in ALS to researchers and the public

Incorporating self-reported questions for telemonitoring to optimize care of patients with MND on noninvasive ventilation (MND OptNIVent)

Early post-marketing experience with edaravone in an unselected group of patients with ALS

Epidemiological and clinical features of amyotrophic lateral sclerosis in a Tunisian cohort

Clinical disease stage related changes of serological factors in amyotrophic lateral sclerosis

Stage-specific riluzole effect in amyotrophic lateral sclerosis: a retrospective study

Amyotrophic lateral sclerosis among patients with a Medicare Advantage prescription drug plan; prevalence, survival and patient characteristics

The split hand in amyotrophic lateral sclerosis: a possible role for the neuromuscular junction

The Edinburgh cognitive and behavioral amyotrophic lateral sclerosis screen (ECAS): sensitivity in differentiating between ALS and Alzheimer’s disease in a Greek population

Predictors of diagnostic delay in amyotrophic lateral sclerosis: a cohort study based on administrative and electronic medical records data

FUS-ALS presenting with myoclonic jerks in a 17-year-old man

Cognitive and behavioral impairments in German and Chinese ALS populations – a post-hoc comparison of national study data

A neuropsychological and behavioral study of PLS

Characteristics of impaired voluntary cough function in individuals with amyotrophic lateral sclerosis

Author response to a Letter to the Editor entitled: Edaravone administration in pivotal clinical study 19 (Authors: Genge, Angela; Brooks, Benjamin)

The revised El Escorial criteria “clinically probable laboratory supported ALS”—once a promising now a superfluous category?

Needs and preferences for psychological interventions of people with motor neuron disease

Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosis

A speech measure for early stratification of fast and slow progressors of bulbar amyotrophic lateral sclerosis: lip movement jitter

Psychological distress and coping styles of caregivers of patients with amyotrophic lateral sclerosis: a longitudinal study

The clinical impact of the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) and neuropsychological intervention in routine ALS care

Excitability in somatosensory cortex correlates with motoric impairment in amyotrophic lateral sclerosis

Physicians’ attitudes toward end-of-life decisions in amyotrophic lateral sclerosis

An epidemiological profile of dysarthria incidence and assistive technology use in the living population of people with MND in Scotland

ALSUntangled No. 47: RT001

Amyotrophic lateral sclerosis mortality rates among ethnic groups in a predominant admixed population in Latin America: a population-based study in Ecuador

Theme 1 Epidemiology and informatics

Genotype–phenotype correlation and evidence for a common ancestor in two Italian ALS patients with the D124G SOD1 mutation

Is the incidence of motor neuron disease higher in French military personnel?

Progressive deterioration of sensory cortex excitability in advanced amyotrophic lateral sclerosis with invasive ventilation

Theme 7 Pre-clinical therapeutic strategies

ALSUntangled No. 52: Glutathione

Speech network regional involvement in bulbar ALS: a multimodal structural MRI study

Atlanta metropolitan area amyotrophic lateral sclerosis (ALS) surveillance: incidence and prevalence 2009–2011 and survival characteristics through 2015

ALSUntangled no. 49: resveratrol

ALSUntangled No. 50: Antifungal Therapy

The rise of innovative clinical trial designs: what’s in it for amyotrophic lateral sclerosis?

Theme 4 In vivo experimental models

Assessing upper limb function with ALSFRS-R in amyotrophic lateral sclerosis patients

Preventive effect of coffee and tea on amyotrophic lateral sclerosis

Theme 3 In vitro experimental models